SRSF3

Serine/arginine-rich splicing factor 3 · P84103 · SRSF3 on Sugi Atlas →

0 patent compounds predicted against SRSF3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SRSF3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer PHASE2COMPLETED
Investigation of Individualised Antisense Oligonucleotides (ASOs) in People With Unique Genetic Variants Causing Severely Debilitating, Life Threatening (SDLT) Central Nervous System (CNS) Conditions PHASE1/PHASE2ACTIVE_NOT_RECRUITING
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing nanRECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Research for Individualized Therapeutics in Rare Genetic Disease nanENROLLING_BY_INVITATION
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia nanRECRUITING
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA nanRECRUITING
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SRSF3 binder may also engage these)

ProteinNameSimilarity
Q3SZR8 1.000 Q3SZR8 →
P84104 1.000 P84104 →
A2RVS6 0.987 A2RVS6 →
O22315 0.987 O22315 →
Q69KL9 0.987 Q69KL9 →
Q6K4N0 0.987 Q6K4N0 →
O81126 0.987 O81126 →
O81127 0.987 O81127 →
Q9LHP2 0.986 Q9LHP2 →
Q1PDV2 0.986 Q1PDV2 →
Q62093 0.985 Q62093 →
SRSF7 Serine/arginine-rich splicing factor 7 0.985 landscape →
Q6PDU1 0.985 Q6PDU1 →
Q5R1W5 0.985 Q5R1W5 →
Q09511 0.985 Q09511 →
SRSF2 Serine/arginine-rich splicing factor 2 0.984 landscape →
Q3T106 0.984 Q3T106 →
Q5R7H2 0.984 Q5R7H2 →
Q23120 0.983 Q23120 →
P30352 0.983 P30352 →
Q06A98 0.983 Q06A98 →
Q3MHR5 0.983 Q3MHR5 →
Q0VCY7 0.982 Q0VCY7 →
Q6NYA0 0.982 Q6NYA0 →
Q6DII2 0.982 Q6DII2 →
Q9FYB7 0.982 Q9FYB7 →
Q18409 0.982 Q18409 →
Q6K9C3 0.981 Q6K9C3 →
SRSF1 Serine/arginine-rich splicing factor 1 0.981 landscape →
Q9V3V0 0.981 Q9V3V0 →